The Impact of Chromium Supplementation on Blood Pressure: A Systematic Review and Dose-Response Meta‑Analysis of

Abolfazl Lari1, Somaye Fatahi1, Mohammad Hassan Sohouli2,3

  • 1Department of Nutrition, School of Public Health, Iran University of Medical Sciences, Shahid Hemmat Highway, Tehran, Iran.

Insights

Chromium supplementation significantly lowers blood pressure, reducing both systolic and diastolic measures. Specific forms like chromium yeast and brewer's yeast showed greater effects on systolic blood pressure.

Area of Science:

  • Nutritional Science
  • Cardiovascular Health
  • Evidence-Based Medicine

Background:

  • Conflicting results exist regarding chromium supplementation's effect on blood pressure.
  • Previous interventional studies show varied outcomes on blood pressure management.

Purpose of the Study:

  • To conduct a systematic review and meta-analysis on chromium supplementation's impact on blood pressure.
  • To synthesize evidence from randomized clinical trials (RCTs) on chromium and blood pressure.

Main Methods:

  • Systematic search of five databases (Web of Science, Scopus, Embase, Google Scholar, PubMed) up to March 2020.
  • Inclusion of 11 randomized clinical trials (RCTs) involving 637 participants.
  • Meta-analysis of RCTs assessing chromium's effect on systolic blood pressure (SBP) and diastolic blood pressure (DBP).

Main Results:

  • Chromium supplementation significantly reduced both SBP (WMD -2.51 mmHg) and DBP (WMD -1.04 mmHg).
  • Subgroup analysis indicated greater SBP reduction with chromium yeast and brewer's yeast.
  • Significant SBP reduction was observed in diabetic patients with chronic heart disease (CHD); dosage influenced SBP changes.

Conclusions:

  • Chromium supplementation effectively decreases both systolic and diastolic blood pressure.
  • Chromium yeast and brewer's yeast forms appear more effective for SBP reduction.
  • Further large-scale RCTs are recommended to validate these findings on blood pressure management.
Abstract

Related Concept Videos

Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
166
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.0K
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
207
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
87
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
217